Sphingosine kinase 2 deficiency increases proliferation and migration of renal mouse mesangial cells and fibroblasts

References

Alemany, R., van Koppen, C.J., Danneberg, K., Ter Braak, M., and Meyer Zu Heringdorf, D. (2007). Regulation and functional roles of sphingosine kinases. Naunyn-Schmiedeberg’s Arch. Pharmacol. 374, 413–428.Suche in Google Scholar

An, S., Zheng, Y., and Bleu, T. (2000). Sphingosine 1-phosphate-induced cell proliferation, survival, and related signaling events mediated by G protein-coupled receptors Edg3 and Edg5. J. Biol. Chem. 275, 288–296.10.1074/jbc.275.1.288Suche in Google Scholar PubMed

Antoon, J.W., White, M.D., Meacham, W.D., Slaughter, E.M., Muir, S.E., Elliott, S., Rhodes, L.V., Ashe, H.B., Wiese, T.E., Smith, C.D., et al. (2010). Antiestrogenic effects of the novel sphingosine kinase-2 inhibitor ABC294640. Endocrinology 151, 5124–5135.10.1210/en.2010-0420Suche in Google Scholar PubMed PubMed Central

Antoon, J.W., White, M.D., Slaughter, E.M., Driver, J.L., Khalili, H.S., Elliott, S., Smith, C.D., Burow, M.E., and Beckman, B.S. (2011). Targeting NF-kB mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2. Cancer Biol. Ther. 11, 678–689.10.4161/cbt.11.7.14903Suche in Google Scholar PubMed PubMed Central

Arikawa, K., Takuwa, N., Yamaguchi, H., Sugimoto, N., Kitayama, J., Nagawa, H., Takehara, K., and Takuwa, Y. (2003). Ligand-dependent inhibition of B16 melanoma cell migration and invasion via endogenous S1P2 G protein-coupled receptor. Requirement of inhibition of cellular RAC activity. J. Biol. Chem. 278, 32841–32851.10.1074/jbc.M305024200Suche in Google Scholar PubMed

Baker, D.A., Eudaly, J., Smith, C.D., Obeid, L.M., and Gilkeson, G.S. (2013). Impact of sphingosine kinase 2 deficiency on the development of TNF-a-induced inflammatory arthritis. Rheumatol. Int. 33, 2677–2681.10.1007/s00296-012-2493-2Suche in Google Scholar PubMed PubMed Central

Bessa, C., Pereira, C., Leao, M., Maciel, C., Gomes, S., Goncalves, J., Corte-Real, M., Costa, V., and Saraiva, L. (2013). Using yeast to uncover the regulation of protein kinase Cdelta by ceramide. FEMS Yeast Res. 13, 700–705.10.1111/1567-1364.12069Suche in Google Scholar PubMed

Calise, S., Blescia, S., Cencetti, F., Bernacchioni, C., Donati, C., and Bruni, P. (2012). Sphingosine 1-phosphate stimulates proliferation and migration of satellite cells: role of S1P receptors. Biochim. Biophys. Acta. 1823, 439–450.10.1016/j.bbamcr.2011.11.016Suche in Google Scholar PubMed

Conner, D.A. (2001). Mouse embryo fibroblast (MEF) feeder cell preparation. Curr. Protoc. Mol. Biol. Chapter 23, Unit 23 22.10.1002/0471142727.mb2302s51Suche in Google Scholar PubMed

Döll, F., Pfeilschifter, J., and Huwiler, A. (2005). The epidermal growth factor stimulates sphingosine kinase-1 expression and activity in the human mammary carcinoma cell line MCF7. Biochim. Biophys. Acta. 1738, 72–81.10.1016/j.bbalip.2005.12.001Suche in Google Scholar PubMed

Döll, F., Pfeilschifter, J., and Huwiler, A. (2007). Prolactin upregulates sphingosine kinase-1 expression and activity in the human breast cancer cell line MCF7 and triggers enhanced proliferation and migration. Endocr. Relat. Cancer 14, 325–335.10.1677/ERC-06-0050Suche in Google Scholar PubMed

Favata, M.F., Horiuchi, K.Y., Manos, E.J., Daulerio, A.J., Stradley, D.A., Feeser, W.S., Van Dyk, D.E., Pitts, W.J., Earl, R.A., Hobbs, F., et al. (1998). Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273, 18623–18632.10.1074/jbc.273.29.18623Suche in Google Scholar PubMed

French, K.J., Schrecengost, R.S., Lee, B.D., Zhuang, Y., Smith, S.N., Eberly, J.L., Yun, J.K., and Smith, C.D. (2003). Discovery and evaluation of inhibitors of human sphingosine kinase. Cancer Res. 63, 5962–5969.Suche in Google Scholar

French, K.J., Upson, J.J., Keller, S.N., Zhuang, Y., Yun, J.K., and Smith, C.D. (2006). Antitumor activity of sphingosine kinase inhibitors. J. Pharmacol. Exp. Ther. 318, 596–603.10.1124/jpet.106.101345Suche in Google Scholar PubMed

French, K.J., Zhuang, Y., Maines, L.W., Gao, P., Wang, W., Beljanski, V., Upson, J.J., Green, C.L., Keller, S.N., and Smith, C.D. (2010). Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2. J. Pharmacol. Exp. Ther. 333, 129–139.10.1124/jpet.109.163444Suche in Google Scholar PubMed PubMed Central

Goparaju, S.K., Jolly, P.S., Watterson, K.R., Bektas, M., Alvarez, S., Sarkar, S., Mel, L., Ishii, I., Chun, J., Milstien, S., et al. (2005). The S1P2 receptor negatively regulates platelet-derived growth factor-induced motility and proliferation. Mol. Cell. Biol. 25, 4237–4249.10.1128/MCB.25.10.4237-4249.2005Suche in Google Scholar PubMed PubMed Central

Hait, N.C., Bellamy, A., Milstien, S., Kordula, T., and Spiegel, S. (2007). Sphingosine kinase type 2 activation by ERK-mediated phosphorylation. J. Biol. Chem. 282, 12058–12065.10.1074/jbc.M609559200Suche in Google Scholar PubMed

Hall, A. (1990). The cellular functions of small GTP-binding proteins. Science 249, 635–640.10.1126/science.2116664Suche in Google Scholar PubMed

Hofmann, L.P., Ren, S., Schwalm, S., Pfeilschifter, J., and Huwiler, A. (2008). Sphingosine kinase 1 and 2 regulate the capacity of mesangial cells to resist apoptotic stimuli in an opposing manner. Biol. Chem. 389, 1399–1407.10.1515/BC.2008.160Suche in Google Scholar PubMed

Huwiler, A., Brunner, J., Hummel, R., Vervoordeldonk, M., Stabel, S., van den Bosch, H., and Pfeilschifter, J. (1996). Ceramide-binding and activation defines protein kinase c-Raf as a ceramide-activated protein kinase. Proc. Natl. Acad. Sci. USA 93, 6959–6963.10.1073/pnas.93.14.6959Suche in Google Scholar PubMed PubMed Central

Huwiler, A., Doll, F., Ren, S., Klawitter, S., Greening, A., Romer, I., Bubnova, S., Reinsberg, L., and Pfeilschifter, J. (2006). Histamine increases sphingosine kinase-1 expression and activity in the human arterial endothelial cell line EA.hy 926 by a PKC-alpha-dependent mechanism. Biochim. Biophys. Acta. 1761, 367–376.10.1016/j.bbalip.2006.02.007Suche in Google Scholar PubMed

Huwiler, A., Fabbro, D., and Pfeilschifter, J. (1998). Selective ceramide binding to protein kinase C-a and -d isoenzymes in renal mesangial cells. Biochemistry 37, 14556–14562.10.1021/bi981401iSuche in Google Scholar PubMed

Huwiler, A., Kolter, T., Pfeilschifter, J., and Sandhoff, K. (2000). Physiology and pathophysiology of sphingolipid metabolism and signaling. Biochim. Biophys. Acta. 1485, 63–99.10.1016/S1388-1981(00)00042-1Suche in Google Scholar

Huwiler, A. and Pfeilschifter, J. (2006). Altering the sphingosine-1-phosphate/ceramide balance: a promising approach for tumor therapy. Curr. Pharm. Des. 12, 4625–4635.10.2174/138161206779010422Suche in Google Scholar

Igarashi, N., Okada, T., Hayashi, S., Fujita, T., Jahangeer, S., and Nakamura, S. (2003). Sphingosine kinase 2 is a nuclear protein and inhibits DNA synthesis. J. Biol. Chem. 278, 46832–46839.10.1074/jbc.M306577200Suche in Google Scholar

Ishii, I., Friedman, B., Ye, X., Kawamura, S., McGiffert, C., Contos, J.J., Kingsbury, M.A., Zhang, G., Brown, J.H., and Chun, J. (2001). Selective loss of sphingosine 1-phosphate signaling with no obvious phenotypic abnormality in mice lacking its G protein-coupled receptor, LP(B3)/EDG-3. J. Biol. Chem. 276, 33697–33704.10.1074/jbc.M104441200Suche in Google Scholar

Jo, S.K., Bajwa, A., Ye, H., Vergis, A.L., Awad, A.S., Kharel, Y., Lynch, K.R., and Okusa, M.D. (2009). Divergent roles of sphingosine kinases in kidney ischemia-reperfusion injury. Kidney Int. 75, 167–175.10.1038/ki.2008.400Suche in Google Scholar

Katsuma, S., Hada, Y., Ueda, T., Shiojima, S., Hirasawa, A., Tanoue, A., Takagaki, K., Ohgi, T., Yano, J., and Tsujimoto, G. (2002). Signalling mechanisms in sphingosine 1-phosphate-promoted mesangial cell proliferation. Genes Cells 7, 1217–1230.10.1046/j.1365-2443.2002.00594.xSuche in Google Scholar

Keely, P.J., Conklin, M.W., Gehler, S., Ponik, S.M., and Provenzano, P.P. (2007). Investigating integrin regulation and signaling events in three-dimensional systems. Methods Enzymol. 426, 27–45.10.1016/S0076-6879(07)26002-1Suche in Google Scholar

Klawitter, S., Hofmann, L.P., Pfeilschifter, J., and Huwiler, A. (2007). Extracellular nucleotides induce migration of renal mesangial cells by upregulating sphingosine kinase-1 expression and activity. Br. J. Pharmacol. 150, 271–280.10.1038/sj.bjp.0706983Suche in Google Scholar PubMed PubMed Central

Kunkel, G.T., Maceyka, M., Milstien, S., and Spiegel, S. (2013). Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond. Nat. Rev. Drug Discov. 12, 688–702.10.1038/nrd4099Suche in Google Scholar PubMed PubMed Central

Liang, J., Nagahashi, M., Kim, E.Y., Harikumar, K.B., Yamada, A., Huang, W.C., Hait, N.C., Allegood, J.C., Price, M.M., Avni, D., et al. (2013). Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer. Cancer Cell 23, 107–120.10.1016/j.ccr.2012.11.013Suche in Google Scholar PubMed PubMed Central

Liu, H., Sugiura, M., Nava, V.E., Edsall, L.C., Kono, K., Poulton, S., Milstien, S., Kohama, T., and Spiegel, S. (2000a). Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform. J. Biol. Chem. 275, 19513–19520.10.1074/jbc.M002759200Suche in Google Scholar

Liu, Y., Wada, R., Yamashita, T., Mi, Y., Deng, C.X., Hobson, J.P., Rosenfeldt, H.M., Nava, V.E., Chae, S.S., Lee, M.J., et al. (2000b). Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J. Clin. Invest. 106, 951–961.10.1172/JCI10905Suche in Google Scholar

Liu, H., Toman, R.E., Goparaju, S.K., Maceyka, M., Nava, V.E., Sankala, H., Payne, S.G., Bektas, M., Ishii, I., Chun, J., et al. (2003). Sphingosine kinase type 2 is a putative BH3-only protein that induces apoptosis. J. Biol. Chem. 278, 40330–40336.10.1074/jbc.M304455200Suche in Google Scholar

Muller, G., Ayoub, M., Storz, P., Rennecke, J., Fabbro, D., and Pfizenmaier, K. (1995). PKC zeta is a molecular switch in signal transduction of TNF-a, bifunctionally regulated by ceramide and arachidonic acid. EMBO J. 14, 1961–1969.10.1002/j.1460-2075.1995.tb07188.xSuche in Google Scholar

O’Connor, K. and Chen, M. (2013). Dynamic functions of RhoA in tumor cell migration and invasion. Small GTPases 4, 141–147.10.4161/sgtp.25131Suche in Google Scholar

Okada, T., Ding, G., Sonoda, H., Kajimoto, T., Haga, Y., Khosrowbeygi, A., Gao, S., Miwa, N., Jahangeer, S., and Nakamura, S. (2005). Involvement of N-terminal-extended form of sphingosine kinase 2 in serum-dependent regulation of cell proliferation and apoptosis. J. Biol. Chem. 280, 36318–36325.10.1074/jbc.M504507200Suche in Google Scholar

Okamoto, H., Takuwa, N., Yokomizo, T., Sugimoto, N., Sakurada, S., Shigematsu, H., and Takuwa, Y. (2000). Inhibitory regulation of Rac activation, membrane ruffling, and cell migration by the G protein-coupled sphingosine-1-phosphate receptor EDG5 but not EDG1 or EDG3. Mol. Cell. Biol. 20, 9247–9261.10.1128/MCB.20.24.9247-9261.2000Suche in Google Scholar

Osada, M., Yatomi, Y., Ohmori, T., Ikeda, H., and Ozaki, Y. (2002). Enhancement of sphingosine 1-phosphate-induced migration of vascular endothelial cells and smooth muscle cells by an EDG-5 antagonist. Biochem. Biophys. Res. Commun. 299, 483–487.10.1016/S0006-291X(02)02671-2Suche in Google Scholar

Paik, J.H., Chae, S., Lee, M.J., Thangada, S., and Hla, T. (2001). Sphingosine 1-phosphate-induced endothelial cell migration requires the expression of EDG-1 and EDG-3 receptors and Rho-dependent activation of avb3- and b1-containing integrins. J. Biol. Chem. 276, 11830–11837.10.1074/jbc.M009422200Suche in Google Scholar PubMed

Pertz, O., Hodgson, L., Klemke, R.L., and Hahn, K.M. (2006). Spatiotemporal dynamics of RhoA activity in migrating cells. Nature 440, 1069–1072.10.1038/nature04665Suche in Google Scholar PubMed

Pyne, N.J. and Pyne, S. (2010). Sphingosine 1-phosphate and cancer. Nat. Rev. Cancer 10, 489–503.10.1038/nrc2875Suche in Google Scholar

Rölz, W., Xin, C., Ren, S., Pfeilschifter, J., and Huwiler, A. (2002). Interleukin-1 inhibits angiotensin II-stimulated protein kinase B pathway in renal mesangial cells via the inducible nitric oxide synthase. Eur. J. Pharmacol. 442, 195–203.10.1016/S0014-2999(02)01545-5Suche in Google Scholar

Ruckhäberle, E., Rody, A., Engels, K., Gaetje, R., von Minckwitz, G., Schiffmann, S., Grösch, S., Geisslinger, G., Holtrich, U., Karn, T., et al. (2008). Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer. Breast Cancer Res. Treat. 112, 41–52.10.1007/s10549-007-9836-9Suche in Google Scholar PubMed

Shida, D., Takabe, K., Kapitonov, D., Milstien, S., and Spiegel, S. (2008). Targeting SphK1 as a new strategy against cancer. Curr. Drug Targets 9, 662–673.10.2174/138945008785132402Suche in Google Scholar PubMed PubMed Central

Vivanco, I. and Sawyers, C.L. (2002). The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat. Rev. Cancer 2, 489–501.10.1038/nrc839Suche in Google Scholar PubMed

vom Dorp, F., Sanders, H., Boergermann, C., Lummen, G., Rubben, H., Jakobs, K.H., and Schmidt, M. (2011). Inhibition of Rho-kinase abrogates migration of human transitional cell carcinoma cells: results of an in vitro study. Urol. Int. 86, 220–227.10.1159/000321271Suche in Google Scholar PubMed

Wymann, M.P., Bulgarelli-Leva, G., Zvelebil, M.J., Pirola, L., Vanhaesebroeck, B., Waterfield, M.D., and Panayotou, G. (1996). Wortmannin inactivates phosphoinositide 3-kinase by covalent modification of Lys-802, a residue involved in the phosphate transfer reaction. Mol. Cell Biol. 16, 1722–1733.10.1128/MCB.16.4.1722Suche in Google Scholar PubMed PubMed Central

Zhang, W., Zhao, J., Lee, J.F., Gartung, A., Jawadi, H., Lambiv, W.L., Honn, K.V., and Lee, M.J. (2013). ETS-1-mediated transcriptional up-regulation of CD44 is required for sphingosine-1-phosphate receptor subtype 3-stimulated chemotaxis. J. Biol. Chem. 288, 32126–32137.10.1074/jbc.M113.495218Suche in Google Scholar PubMed PubMed Central